gogo
Amazon cover image
Image from Amazon.com

The exclusion of surgical, therapeutic and diagnostic inventions from patentability under Article 52(4) of the European Patent Convention : a report prepared for the Intellectual Property Institute / Florian Leverve, Jeremy Phillips.

By: Contributor(s): Material type: TextTextPublication details: London : Intellectual Property Institute, [2008]Description: 28 p. ; 30 cmISBN:
  • 9781874001959 (pbk.)
  • 9781874001959
Subject(s): DDC classification:
  • 346.0486 LEV
Contents:
The scope of the exclusion of surgical, therapeutic and diagnostic inventions from patentability (under Article 52(4) of the EPC) is of enormous economic significance to the healthcare industries. This aspect of patent law in Europe was conceived some three decades ago, during which time medical technology and practice have evolved rapidly. In a new publication from the IP Institute, Florian Leverve (Queen Mary IP Research Institute, London) and Jeremy Phillips (IPI research director and well known to IPI members) have examined the policy behind Article 52(4) exclusions and the manner in which this provision has been applied in the EPO. The report investigates whether the exclusion has been broadly or narrowly applied, and whether it is working to achieve its original aims in a consistent way in today\'s healthcare environment-- From Intellectual Property Institute website.
Holdings
Item type Current library Call number Copy number Status Date due Barcode
Long Loan TUS: Midlands, Main Library Athlone General Lending 346.0486 LEV (Browse shelf(Opens below)) 1 Available 205566

The scope of the exclusion of surgical, therapeutic and diagnostic inventions from patentability (under Article 52(4) of the EPC) is of enormous economic significance to the healthcare industries. This aspect of patent law in Europe was conceived some three decades ago, during which time medical technology and practice have evolved rapidly. In a new publication from the IP Institute, Florian Leverve (Queen Mary IP Research Institute, London) and Jeremy Phillips (IPI research director and well known to IPI members) have examined the policy behind Article 52(4) exclusions and the manner in which this provision has been applied in the EPO. The report investigates whether the exclusion has been broadly or narrowly applied, and whether it is working to achieve its original aims in a consistent way in today\'s healthcare environment-- From Intellectual Property Institute website.

Powered by Koha